At-Home style HPV test at Walk-In clinics could boost cancer screening

NCT ID NCT07186530

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether offering women a simple self-collection kit for HPV testing at Express Care clinics (which have evening and weekend hours) increases cervical cancer screening rates. About 500 women aged 30–63 who are overdue for screening will either receive usual care or be invited to self-collect a vaginal swab at the clinic. The goal is to see if this convenient option helps more women get screened and follow up on abnormal results.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
HPV self-collection kit
What this could lead to
If successful, this approach could make cervical cancer screening more convenient and accessible, potentially increasing early detection and prevention.
What could go wrong
This is a single-site study with 500 participants, so results may not apply broadly. The intervention is already FDA-approved, so the main question is about uptake, not efficacy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Mayo Clinic in Rochester

    Rochester, Minnesota, 55905, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.